Sixth Street Specialty Lending (TSLX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
6 Jan, 2026Executive summary
Reported full-year 2024 net investment income of $2.39 per share and adjusted NII of $2.33 per share, with Q4 2024 adjusted NII of $0.61 per share and annualized ROE of 14.4% for Q4 and 14.1% for the year, all within or exceeding guidance.
Net asset value per share increased to $17.16 at year-end 2024, up from $17.04 a year earlier, outperforming the BDC peer group.
Portfolio activity rebounded with the highest investment commitments and repayments since 2021, totaling $1.24 billion in new commitments and $838.9 million funded in 2024.
Activity-based fees and higher interest rates contributed positively, while credit headwinds and tighter spreads were partial offsets.
Board declared a Q4 2024 base dividend of $0.46 per share, a supplemental dividend of $0.07 per share, and a Q1 2025 base dividend of $0.46 per share.
Financial highlights
Q4 2024 adjusted net investment income per share was $0.61; full-year 2024 adjusted NII per share was $2.33; net income per share for 2024 was $2.03.
Total investment income in Q4 2024 reached $123.7 million, with full-year investment income at $482.5 million.
Net asset value per share rose to $17.16 at year-end; adjusted NAV per share was $17.09.
Debt-to-equity ratio at year-end was 1.22x, with $674 million in revolver capacity.
Annualized ROE on net investment income for Q4 2024 was 14.4%; for the year, 14.1%.
Outlook and guidance
Targeting 2025 return on equity on net investment income of 11.5%-12.5%, with full-year 2025 adjusted NII per share expected in the range of $1.97-$2.14.
Guidance assumes a similar interest rate and spread environment as Q4 2024, with conservative assumptions on portfolio turnover and activity-based fees.
Anticipates marginally lowering the drawn spread and undrawn fee on the revolving credit facility upon amendment in Q1 2025.
Latest events from Sixth Street Specialty Lending
- Consistent outperformance in ROE, NAV growth, and dividend coverage with strong portfolio quality.TSLX
Investor presentation2 Mar 2026 - Adjusted NII and ROE exceeded guidance, with strong liquidity and a new JV to boost returns.TSLX
Q4 202513 Feb 2026 - Q3 2025 saw strong net investment income, stable NAV, and robust new investment activity.TSLX
Q3 20253 Feb 2026 - Q2 2024 saw strong net investment income, record NAV, and robust portfolio yields.TSLX
Q2 20242 Feb 2026 - Q3 2024 net investment income was $0.59 per share, with strong yield and stable dividends.TSLX
Q3 202416 Jan 2026 - Proposal seeks approval to issue shares below NAV, with board support and dilution safeguards.TSLX
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, ratify auditor, and review governance and compensation.TSLX
Proxy Filing1 Dec 2025 - Director elections and auditor ratification headline the May 2025 Annual Meeting agenda.TSLX
Proxy Filing1 Dec 2025 - Shareholders will vote on authorizing share issuances below NAV, with board support and dilution limits.TSLX
Proxy Filing1 Dec 2025